2013 - CTS 2013 Congress


This page contains exclusive content for the member of the following sections: TTS, CTS. Log in to view.

Oral Communications 3

8.1 - Loco-regional detection and stimulation of transplanted liver cells by particle-based miRNA depletion

Presenter: Nathanael, Raschzok, Berlin, Germany
Authors: Nathanael Raschzok1,2, Annekatrin Leder1,2, Antje Butter1,2, Susanne Kolano1,2, Duygu Arabacioglu1,2, Luisa De Sousa Lisboa1,2, Wiebke Werner1,2, Steffen Lippert1,2, Christian Schmidt1,2, Igor M. Sauer1,2

Loco-regional detection and stimulation of transplanted liver cells by particle-based miRNA depletion

Nathanael Raschzok1,2, Annekatrin Leder1,2, Antje Butter1,2, Susanne Kolano1,2, Duygu Arabacioglu1,2, Luisa De Sousa Lisboa1,2, Wiebke Werner1,2, Steffen Lippert1,2, Christian Schmidt1,2, Igor M. Sauer1,2

1General, Visceral, and Transplant Surgery, Experimental Surgery and Regenerative Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany; 2microparticles GmbH, Berlin, Germany

 

Introduction:
Liver cell transplantation (LCT) is a promising treatment option for children with inborn metabolic liver disease. However, both detection and proliferation stimulation of transplanted liver cells is challenging. Aim of this study was the development of a functionalized iron oxide particle for detection of transplanted liver cells by MRI and simultaneous loco-regional stimulation by targeting of specific microRNAs (miRNAs).
 
Methods:
Silica-based micron-sized iron oxide particles (sMPIOs) were used as carrier particles. Locked nucleic acid (LNA) antisense oligonucleotides specific for hsa-let-7g or rno-let-7g were covalently bound on the surface of the particles. For in vitro studies, primary human hepatocytes were labeled with LNA-sMPIO and miRNA depletion was investigated using qRT-PCR and Northern Blot. Protein expression of Cyclin D1 and c-Myc was investigated by western blot. Light and laser scanning microscopy were used to verify the intracellular localization of the particles. For in vivo proof of concept, male rat hepatocytes labeled with LNA-sMPIOs were transplanted to female Wistar rats via intrasplenic injection. 3.0 Tesla MRI was performed 7 days following transplantation. Cell engraftment was analyzed by Prussian Blue staining and Fish-Typing for the Y-chromosome.
 
Results:
In vitro incubation with LNA-sMPIOs enabled hepatocyte labeling within 4 hours.  Particles were located near the cell nucleus, while not appearing to be encapsulated from cellular membranes. Labeling of human hepatocytes with LNA-sMPIOs lead to a decrease of endogenous let-7g levels by more than 85%. Knockdown efficiency was similar to controls with transfected cells.Cyclin D1 and c-Myc, which are both targets of let-7g, were significantly upregulated upon LNA-sMPIO internalization. In vivo, LNA-sMPIO labeled liver cells were detectable as punctual signal decrease of the liver and could be correlated with the presence of Prussian blue positive donor cells.
 
Discussion:
Our results demonstrate the feasibility of particle-based miRNA depletion. Moreover, we show functional effects on the protein expression of labeled cells. In vivo, the micron-sized iron core enabled non-invasive detection of transplanted cells.  Our concept could be therefore suitable for LCT as well as for further cellular therapies where visualization and therapeutic modification is necessary.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada